[How great is the risk of malignancy from immunosuppressives?].
作者信息
Sodomann C P, Gropp C
出版信息
Internist (Berl). 1979 Dec;20(12):571-84.
PMID:398353
Abstract
摘要
相似文献
1
[How great is the risk of malignancy from immunosuppressives?].
Internist (Berl). 1979 Dec;20(12):571-84.
2
[Malignant neoplasms after organ transplantation].
Vopr Onkol. 1980;26(11):107-13.
3
[Development of lymphoma and leukemia in patients receiving immunosuppressive drugs].
Pol Tyg Lek. 1980 Mar 17;35(11):411-4.
4
[Significance of immunosuppression for the origin and growth of malignant tumors].[免疫抑制对恶性肿瘤起源和生长的意义]
Dtsch Med Wochenschr. 1971 Jan 22;96(4):170-4. doi: 10.1055/s-0028-1108223.
5
Another look at immunologic surveillance.再看免疫监视。
N Engl J Med. 1975 Jul 24;293(4):181-4. doi: 10.1056/NEJM197507242930406.
6
Predictive oncology. 3.
Int Surg. 1973 Nov-Dec;58(11):768-73.
7
Tumour development following immunosuppression.免疫抑制后的肿瘤发展。
Proc R Soc Med. 1970 Oct;63(10):1077-80. doi: 10.1177/003591577006301055.
8
Malignancy as a complication of immunosuppressive therapy.恶性肿瘤作为免疫抑制治疗的一种并发症。
Adv Intern Med. 1971;17:95-123.
9
[Immunosuppression, genesis and growth of malignant tumours].
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1972;78(1):42-50. doi: 10.1007/BF00284311.
10
The role of immunosuppression in the genesis and growth of malignant tumours.
Ger Med Mon. 1971 Spring;1(1):16-21.
Zotero 插件